These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34237741)

  • 1. Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Reduced in Euthyroid Children with Newly Diagnosed Hashimoto's Thyroiditis: A Pilot Study.
    Aversa T; Ruggeri RM; Corica D; Cristani MT; Pepe G; Vicchio TM; Alibrandi A; Trimarchi F; Cannavò S; Pajno GB; Wasniewska MG
    Horm Res Paediatr; 2021; 94(3-4):144-150. PubMed ID: 34237741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
    Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
    J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis.
    Ruggeri RM; Vicchio TM; Cristani M; Certo R; Caccamo D; Alibrandi A; Giovinazzo S; Saija A; Campennì A; Trimarchi F; Gangemi S
    Thyroid; 2016 Apr; 26(4):504-11. PubMed ID: 26854840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
    Csiha S; Molnár I; Halmi S; Hutkai D; Lőrincz H; Somodi S; Katkó M; Harangi M; Paragh G; Nagy EV; Berta E; Bodor M
    Front Endocrinol (Lausanne); 2023; 14():1187725. PubMed ID: 37305044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum interleukin-37 (IL-37) levels correlate with oxidative stress parameters in Hashimoto's thyroiditis.
    Ruggeri RM; Cristani M; Vicchio TM; Alibrandi A; Giovinazzo S; Saija A; Campennì A; Trimarchi F; Gangemi S
    J Endocrinol Invest; 2019 Feb; 42(2):199-205. PubMed ID: 29796799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Dietary Habits on Oxidative Stress Markers in Hashimoto's Thyroiditis.
    Ruggeri RM; Giovinazzo S; Barbalace MC; Cristani M; Alibrandi A; Vicchio TM; Giuffrida G; Aguennouz MH; Malaguti M; Angeloni C; Trimarchi F; Hrelia S; Campennì A; Cannavò S
    Thyroid; 2021 Jan; 31(1):96-105. PubMed ID: 32729374
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of paraoxonase activity and association with serum advanced glycation end products as reliable markers of oxidative stress in Hashimoto's thyroiditis.
    Ruggeri RM; Cristani MT; Crupi F; Molonia MS; Burduja N; Alibrandi A; Campennì A; Cannavò S
    Minerva Endocrinol (Torino); 2022 Oct; ():. PubMed ID: 36251022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean platelet volume in euthyroid patients with Hashimoto's thyroiditis.
    Carlioglu A; Timur O; Durmaz SA; Ayhan ME
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):282-4. PubMed ID: 25485785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-Müllerian hormone levels in euthyroid adolescent girls with Hashimoto's thyroiditis: relationship to antioxidant status.
    Erol O; Parlak M; Ellidağ HY; Parlak AE; Derbent AU; Eren E; Yılmaz N
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():204-9. PubMed ID: 27343736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-specific rheumatic manifestations in patients with Hashimoto's thyroiditis: a pilot cross-sectional study.
    Giuffrida G; Bagnato G; Campennì A; Giovinazzo S; Keller KP; Alibrandi A; Roberts WN; Trimarchi F; Ruggeri RM
    J Endocrinol Invest; 2020 Jan; 43(1):87-94. PubMed ID: 31301020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Possible Impact of Hyperuricemia on Serum Soluble Receptor for Advanced Glycation end Products (sRAGE) Levels in Teenagers: A Case Control Study.
    Lemiesz M; Tenderenda-Banasiuk E; Sosnowska D; Rybi-Szumińska A; Storonowicz J; Lemiesz T; Wasilewska A
    Curr Pharm Des; 2018; 24(27):3232-3239. PubMed ID: 30101695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto's thyroiditis compared to non-autoimmune thyroid disease and healthy controls.
    Ruggeri RM; Minciullo P; Saitta S; Giovinazzo S; Certo R; Campennì A; Trimarchi F; Gangemi S; Benvenga S
    Hormones (Athens); 2014; 13(3):338-44. PubMed ID: 25079457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D
    Giovinazzo S; Vicchio TM; Certo R; Alibrandi A; Palmieri O; Campennì A; Cannavò S; Trimarchi F; Ruggeri RM
    Endocrine; 2017 Feb; 55(2):599-606. PubMed ID: 27043843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
    Corica D; Aversa T; Ruggeri RM; Cristani M; Alibrandi A; Pepe G; De Luca F; Wasniewska M
    Front Endocrinol (Lausanne); 2019; 10():426. PubMed ID: 31316471
    [No Abstract]   [Full Text] [Related]  

  • 16. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum-soluble receptor for advanced glycation end products (sRAGE) and disease activity in rheumatoid arthritis patients.
    Jafari Nakhjavani MR; Jafarpour M; Ghorbanihaghjo A; Abedi Azar S; Malek Mahdavi A
    Mod Rheumatol; 2019 Nov; 29(6):943-948. PubMed ID: 30474471
    [No Abstract]   [Full Text] [Related]  

  • 18. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
    Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
    Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of circulating sTWEAK in the pathogenesis of Hashimoto's thyroiditis - a pilot study.
    Altay M; Ateş İ; Yılmaz FM; Topçuoğlu C; Kaplan M
    Endokrynol Pol; 2016; 67(6):562-566. PubMed ID: 26884302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the Relationship Between Serum Ghrelin Levels and Metabolic Parameters and Autoimmunity in Patients with Euthyroid Hashimoto's Thyroiditis.
    Biyikli HH; Arduc A; Isik S; Ozuguz U; Caner S; Dogru F; Shorbagi AI; Erden G; Berker D; Guler S
    Endocr Pract; 2014 Aug; 20(8):818-24. PubMed ID: 24518184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.